Rianne Kruize

PhD student

Contact info

  • Address

    Vrije Universiteit Amsterdam
    Center for Neurogenomics and Cognitive Research (CNCR)
    Department of Complex Trait Genetics
    Research Building
    De Boelelaan 1100
    1081 HZ Amsterdam
    The Netherlands

  • E-mail

Profile image of Rianne Kruize

Short CV

2025 – present PhD student AUMC / Vrije Universiteit Amsterdam
2024-2025 Medical Doctor, dept. of Clinical Genetics Antoni van Leeuwenhoek
2020-2025 MSc. Biomedical Sciences (cum laude) University of Amsterdam
2021-2024 MSc. Medicine University of Amsterdam
2017-2020 BSc. Medicine (cum laude) University of Amsterdam
2017-2020 BSc. Biomedical Sciences (cum laude University of Amsterdam

Research

My project aims to provide insights into disease mechanisms in rare genetic developmental disorders with intellectual disability and to explore novel therapeutic strategies using patient-derived induced pluripotent stem cell (iPSC) models. I will focus on three representative disorders, namely Menke-Hennekam syndrome, Marshall-Smith syndrome and Pitt-Hopkins syndrome. These syndromes come with a high burden of disease that highly impacts the lives of the affected individuals and their families. Treatment options are limited to symptomatic treatment, largely due to absence of suitable preclinical models. I will establish brain organoids derived from affected individuals to gain a better understanding of the molecular and cellular mechanisms underlying neurodevelopmental abnormalities. We will assess whether therapeutic modulation of affected pathways can improve disease-associated phenotypes, providing a foundation for novel therapeutic approaches. Through this project, I aim to establish a versatile stem cell-based platform to investigate neurodevelopmental disorders, providing both mechanistic insight and a foundation for developing targeted therapeutic approaches.

Alongside the laboratory work, I will establish a clinical database for MRSHSS. This database will provide an up-to-date overview of the syndrome, thereby improving the understanding of the syndrome’s clinical spectrum and supporting revisions of the current standards of care.